Immunosuppression by the bisdioxopiperazines ICRF 154 and 159.
D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects; D000970:Antineoplastic Agents / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002645:Chickens; D003520:Cyclophosphamide / Q000494:pharmacology; D005260:Female; D006084:Graft Rejection / Q000187:drug effects*; D006087:Graft vs Host Reaction / Q000187:drug effects*; D006968:Hypersensitivity, Delayed / Q000188:drug therapy*; D007166:Immunosuppressive Agents; D051379:Mice; D010879:Piperazines / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D010879:Piperazines; D003520:Cyclophosphamide